These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 26937257)

  • 1. Diagnostic and prognostic value of SHOX2 and SEPT9 DNA methylation and cytology in benign, paramalignant, and malignant ascites.
    Jung M; Pützer S; Gevensleben H; Meller S; Kristiansen G; Dietrich D
    Clin Epigenetics; 2016; 8():24. PubMed ID: 26937257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic and prognostic value of SHOX2 and SEPT9 DNA methylation and cytology in benign, paramalignant and malignant pleural effusions.
    Dietrich D; Jung M; Puetzer S; Leisse A; Holmes EE; Meller S; Uhl B; Schatz P; Ivascu C; Kristiansen G
    PLoS One; 2013; 8(12):e84225. PubMed ID: 24386354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of quantification algorithms for circulating cell-free DNA methylation biomarkers in blood plasma from cancer patients.
    de Vos L; Gevensleben H; Schröck A; Franzen A; Kristiansen G; Bootz F; Dietrich D
    Clin Epigenetics; 2017; 9():125. PubMed ID: 29213339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promoter hypermethylation of
    Branchi V; Schaefer P; Semaan A; Kania A; Lingohr P; Kalff JC; Schäfer N; Kristiansen G; Dietrich D; Matthaei H
    Clin Epigenetics; 2016; 8():133. PubMed ID: 27999621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential of quantitative SEPT9 and SHOX2 methylation in plasmatic circulating cell-free DNA as auxiliary staging parameter in colorectal cancer: a prospective observational cohort study.
    Bergheim J; Semaan A; Gevensleben H; Groening S; Knoblich A; Dietrich J; Weber J; Kalff JC; Bootz F; Kristiansen G; Dietrich D
    Br J Cancer; 2018 May; 118(9):1217-1228. PubMed ID: 29610456
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Semaan A; van Ellen A; Meller S; Bergheim D; Branchi V; Lingohr P; Goltz D; Kalff JC; Kristiansen G; Matthaei H; Pantelis D; Dietrich D
    Clin Epigenetics; 2016; 8():100. PubMed ID: 27660666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Free-Circulating Methylated DNA in Blood for Diagnosis, Staging, Prognosis, and Monitoring of Head and Neck Squamous Cell Carcinoma Patients: An Observational Prospective Cohort Study.
    Schröck A; Leisse A; de Vos L; Gevensleben H; Dröge F; Franzen A; Wachendörfer M; Schröck F; Ellinger J; Teschke M; Wilhelm-Buchstab T; Landsberg J; Holdenrieder S; Hartmann G; Field JK; Bootz F; Kristiansen G; Dietrich D
    Clin Chem; 2017 Jul; 63(7):1288-1296. PubMed ID: 28515105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment Response Monitoring in Patients with Advanced Malignancies Using Cell-Free SHOX2 and SEPT9 DNA Methylation in Blood: An Observational Prospective Study.
    de Vos L; Jung M; Koerber RM; Bawden EG; Holderried TAW; Dietrich J; Bootz F; Brossart P; Kristiansen G; Dietrich D
    J Mol Diagn; 2020 Jul; 22(7):920-933. PubMed ID: 32361006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA methylation of the homeobox genes PITX2 and SHOX2 predicts outcome in non-small-cell lung cancer patients.
    Dietrich D; Hasinger O; Liebenberg V; Field JK; Kristiansen G; Soltermann A
    Diagn Mol Pathol; 2012 Jun; 21(2):93-104. PubMed ID: 22555092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of the SHOX2/PTGER4 DNA Methylation Marker Panel for Plasma-Based Discrimination between Patients with Malignant and Nonmalignant Lung Disease.
    Weiss G; Schlegel A; Kottwitz D; König T; Tetzner R
    J Thorac Oncol; 2017 Jan; 12(1):77-84. PubMed ID: 27544059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of SHOX2 methylation as an aid to cytology in lung cancer diagnosis.
    Ilse P; Biesterfeld S; Pomjanski N; Wrobel C; Schramm M
    Cancer Genomics Proteomics; 2014; 11(5):251-8. PubMed ID: 25331797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors Affecting Performance of DNA Methylation as a Potential Biomarker in Ascites for Peritonitis and Peritoneal Carcinomatosis.
    Bose K; Scurt FG; Thon C; Franke S; Schulz C; Malfertheiner P; Link A
    J Gastrointestin Liver Dis; 2023 Jun; 32(2):206-215. PubMed ID: 37345611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-Free
    Jung M; Ellinger J; Gevensleben H; Syring I; Lüders C; de Vos L; Pützer S; Bootz F; Landsberg J; Kristiansen G; Dietrich D
    Clin Chem; 2019 Apr; 65(4):559-568. PubMed ID: 30626634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A detection panel of novel methylated DNA markers for malignant pleural effusion.
    Liang C; Liu N; Zhang Q; Deng M; Ma J; Lu J; Yin Y; Wang J; Miao Y; She B; Li Q; Hou G
    Front Oncol; 2022; 12():967079. PubMed ID: 36176402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [DNA methylation detection of SHOX2 and PTGER4 in plasma contributes to differential diagnosis of pulmonary nodule patients].
    Chu X; Zhao W; Wang B
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2019 Apr; 35(4):357-361. PubMed ID: 31167696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postoperative serum methylation levels of TAC1 and SEPT9 are independent predictors of recurrence and survival of patients with colorectal cancer.
    Tham C; Chew M; Soong R; Lim J; Ang M; Tang C; Zhao Y; Ong SY; Liu Y
    Cancer; 2014 Oct; 120(20):3131-41. PubMed ID: 24925595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Novel Diagnosis Method Based on Methylation Analysis of SHOX2 and Serum Biomarker for Early Stage Lung Cancer.
    Huang W; Huang H; Zhang S; Wang X; Ouyang J; Lin Z; Chen P
    Cancer Control; 2020; 27(1):1073274820969703. PubMed ID: 33167712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SHOX2 DNA methylation is a biomarker for the diagnosis of lung cancer in plasma.
    Kneip C; Schmidt B; Seegebarth A; Weickmann S; Fleischhacker M; Liebenberg V; Field JK; Dietrich D
    J Thorac Oncol; 2011 Oct; 6(10):1632-8. PubMed ID: 21694641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA Methylation Analysis of Free-Circulating DNA in Body Fluids.
    Jung M; Kristiansen G; Dietrich D
    Methods Mol Biol; 2018; 1708():621-641. PubMed ID: 29224167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The value of SHOX2 methylation test in peripheral blood samples used for the differential diagnosis of lung cancer and other lung disorders.
    Konecny M; Markus J; Waczulikova I; Dolesova L; Kozlova R; Repiska V; Novosadova H; Majer I
    Neoplasma; 2016; 63(2):246-53. PubMed ID: 26774146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.